4th Quarter - Report

JENCKES AND ASSOCIATES for NABI BIOPHARMACEUTICALS

Period 4th Quarter 2009 Filed Jan 20, 2010 Signed by Linda Jenckes, President

Official filing
Firm
JENCKES AND ASSOCIATES
Client
NABI BIOPHARMACEUTICALS
Income
$5,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Business development with the federal government regarding vaccines for smoking cessation and staph aureons.

LobbyistCovered position, as disclosed
LINDA JENCKES —

Contacted: Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA); Defense, Dept of (DOD)

Health Issues HCR

Business development with the federal government regarding vaccines for smoking cessation and staph aureons.

LobbyistCovered position, as disclosed
LINDA JENCKES —

Contacted: Veterans Affairs, Dept of (VA); Health & Human Services, Dept of (HHS); Defense, Dept of (DOD)

Veterans VET

Business development with the federal government regarding vaccines for smoking cessation and staph aureons.

LobbyistCovered position, as disclosed
LINDA JENCKES —

Contacted: Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA); Defense, Dept of (DOD)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.